Customization: | Available |
---|---|
CAS No.: | 915087-33-1 |
Formula: | C21h16f4n4o2s |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
MDV-3100 Basic information |
Pharmacological action Indications Clinical evaluation Side effects Biological activity In vivo studies |
Product Name: | MDV-3100 |
Synonyms: | 4-{3-[4-CYANO-3-(TRIFLUOROMETHYL)PHENYL]-5,5-DIMETHYL-4-OXO-2-SULFANYLIDENEIMIDAZOLIDIN-1-YL}-2-FLUO;4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N;BenzaMide,4-[3-[4-cyano-3-(trifluoroMethyl)phenyl]-5,5-diMethyl-4-oxo-2-thioxo-1-iMidazolidinyl]-2-fluoro-N-Methyl-;Enzalutamide Carboxylic acid;4-[3-(4-Ethynyl-3-trifluoromethyl-phenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide;4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide MDV 3100;MDV3100,Menzalutamide;Xtandi (enzalutamide) (androgen receptor inhibitor) |
CAS: | 915087-33-1 |
MF: | C21H16F4N4O2S |
MW: | 464.4359528 |
EINECS: | 805-022-1 |
Product Categories: | -;Apoptosis;Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Inhibitor |
Mol File: | 915087-33-1.mol |
Chemical and Physical Properties | |
Appearance | White to off-white(solid) |
Quality standard | Purity 99% min |
Handling and storage | |
Safety and Hazards | The shanghai Research Institute of Chemical industry testing center identification conclusion :1 None hazard identification, 2 The substance is not subject to IATA DGR, 3 Non packing requirements. |
Handling and storage | Keep container tightly closed in a dry and well-ventilated place. Light sensitive. |
Sample package | Aluminium foil bag |
Commercial package | Fiber drum |
UN Code | Not classfied |
HS Code | 29349990.90 |
Shipping group | Shipment at ambient temperature for no controlled and no dangerous goods |
Sales restriction | NO |
Origin | China |
Application | |
Drug Indication | Enzalutamide is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. |
Formulations/Preparations | taken by mouth |
Quality Control of Health Sources
1) A system in accordance with GMP standard, supervision on whole production process.
2) Health Sources is equipped with advanced detecting device, such as AFS, GC, HPLC, UV etc, supply the
detailed Certificate of Analysis.
3) Procurement-Strictly on selecting raw materials.
4) Production-Strictly according to the standard specifications, conform to USP, EP, BP, CP, AJI, FCC etc
pharmaceutical and/or food standards.
5) Warehousing and storage: Clear and dry condition with suitable temperature.
6) Transportation - Audit and supervise the logistics environment to ensure storage safety.
7) Keep samples for all batches goods to be traceable in case of quality discrepance.
Certification